Alternatives to naltrexone in animal models

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 8 SUPPL., 1996, Pages

  Overstreet, David H ^a   McArthur, Robert ^b   Sinclair, J David ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b PFIZER INC   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [4,4 BIS(4 FLUOROPHENYL)BUTYL] 1 PIPERAZINYL]NICOTINIC ACID; ACAMPROSATE; AMPEROZIDE; NALTREXONE; NPI 028; OPIATE ANTAGONIST; PROTIRELIN DERIVATIVE; PUERARIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; TALTIRELIN; UNCLASSIFIED DRUG;

ALCOHOLISM; CONFERENCE PAPER; DRUG ACTIVITY; DRUG DEVELOPMENT; DRUG EFFECT; DRUG RESEARCH; DRUG SCREENING; HERBAL MEDICINE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0029829037     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01782.x     Document Type: Conference Paper

References (24)

1. Sinclair JD: Drugs to decrease alcohol drinking. Ann Med 22:357-362, 1990
2. Sinclair JR: Laboratory animal research in the discovery and development of the new alcoholism treatment using opioid antagonists. Scand J Lab Animal Sci 1996 (in press)
3. Hyytia P, Sinclair JD: Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats, Alcohol Clin Exp Res 17:631-636 1993
4. O'Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld RS, Meyer RE, Rounsaville B: Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 53:217-224, 1996
5. Overstreet DH, Rezvani AH, Pucilowski O, Janowsky DS: 5-HT receptors: Implications for the neuropharmacology of alcohol and alcoholism. Alcohol Alcohol (suppl) 2:207-212, 1995
6. Svartengren J, Simonsson P: Receptor binding properties of amperozide. Pharmacol Toxicol (Suppl)1:8-11, 1990.
7. Albinsson A, Bjork A, Svartengren J, Klint T, Andersson G: Preclinical pharmacology of FG5893: A potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors. Eur Pharmacol 261:285-294, 1994
8. Hjorth S, Pettersson G: 5-HT1A outoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxy-tryptamine neurochemistry in vivo. Eur J Pharmacol 238:357-367, 1993
9. Overstreet DH, McArthur RA, Rezvani AH, Post C: Amperozide and FG5974: 5-HT2A receptor antagonists reduce alcohol intake in three strains of alcohol-referring rats. Alcohol Clin Exp Res 20:15A, 1996 (abstr)
10. Overstreet DH, Lee DYW, Rezvani AH, Criswell HC, Pei Y-W, Janowsky DS: Suppression of alcohol intake by the Chinese herbal medicine NPI-028 and its derivatives. Alcohol Clin Exp Res 20:221-227, 1996
11. Overstreet DH, Rezvani AH, Lee YW: Selective alcohol intake-suppressant effects of the isoflavones daidzin, daidzein and puerarin in alcohol-preferring FH rats. Alcohol Clin Exp Res 20:16A, 1996 (abstr)
12. Lin RC, Guthrie S, Xie CY, Mai K, Lee YW, Lumeng L, Li T-K: Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol Clin Exp Res 20: 659-663, 1996
13. Rezvani AH, Garbutt JC, Shimada K, Garges PL, Janowsky DS, Mason GA: Attenuation of alcohol preference in alcohol preferring rats by a novel TRH analogue TA-0910. Alcohol Clin Exp Res 16:326-330, 1992
14. Rezvani AH, Mason GA: Involement of D2 receptors in the suppressant effect of the TRH analog TA-0910 on alcohol intake. Soc Neuro Abs 21:1703, 1995 (abstr)
15. Mason GA, Rezvani AH, Grady DR, Garbutt JC: The sub-chronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring P rats. Alcohol Clin Exp Res 18:1196-1201, 1994
16. Schreiber R, Opitz K, Glase T, De Vry J: Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors. Psychopharmacology 112:100-110, 1993
17. Lovinger DM: Ethanol potentiation of 5-HT3 receptor mediated ion current in NCB-20 neuroblastoma cells. Neurosci Lett 122:57-60, 1991
18. Grant, KA: The role of 5-HT3 receptors in drug dependence. Drug Alcohol Depend 38:155-171, 1995
19. Tomkins DM, Le AD, Sellers EM: Effects of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure. Psychopharmacology 117:479-485, 1995
20. Sellers EM, Toneatto T, Romach MK, Somer GR, Sobell LC, Sobell MB: Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence. Alcohol Clin Exp Res 18:879-885, 1994
21. Le AD, Sellers EM: Interaction between opiate and 5-HT3 receptor antagonists in the regulation of alcohol intake. Alcohol Alcohol (suppl) 2: 545-549, 1994
22. Spanagel R, Putzke J, Slefferl A, Schobitz B, Zieglgansberger W: Acamprosate and alcohol. II. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305:45-50, 1996
23. Spanagel R, Zieglgansberger W, Hundt W: Acamprosate and alcohol: III Effects on alcohol discrimination in the rat. Eur J Pharmacol 305:51-56, 1996
24. Spanagel R, Holter SM, Allingham K, Landgraf R, Zieglgansberger W: Acamprosate and alcohol I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305:38-44, 1996